Justin Walsh

Stock Analyst at Jones Trading

(1.88)
# 3,111
Out of 4,893 analysts
40
Total ratings
38.89%
Success rate
-8.7%
Average return

Stocks Rated by Justin Walsh

Theratechnologies
Jul 3, 2025
Downgrades: Hold
Price Target: n/a
Current: $3.16
Upside: -
Lantheus Holdings
Jun 23, 2025
Maintains: Buy
Price Target: $122$109
Current: $83.83
Upside: +30.03%
VolitionRx
Jun 10, 2025
Initiates: Buy
Price Target: $3
Current: $0.66
Upside: +353.86%
BioLineRx
May 30, 2025
Upgrades: Buy
Price Target: $12
Current: $4.95
Upside: +142.42%
Clene
Apr 23, 2025
Initiates: Buy
Price Target: $30
Current: $3.78
Upside: +693.65%
Monopar Therapeutics
Apr 2, 2025
Downgrades: Hold
Price Target: n/a
Current: $38.26
Upside: -
Serina Therapeutics
Mar 11, 2025
Initiates: Buy
Price Target: $11
Current: $5.90
Upside: +86.57%
Alto Neuroscience
Dec 16, 2024
Initiates: Buy
Price Target: $18
Current: $2.58
Upside: +597.67%
Rapport Therapeutics
Oct 18, 2024
Initiates: Buy
Price Target: $42
Current: $15.38
Upside: +173.08%
Y-mAbs Therapeutics
Jul 11, 2024
Initiates: Buy
Price Target: $23
Current: $4.53
Upside: +407.73%
Maintains: Buy
Price Target: $15$22
Current: $4.11
Upside: +435.28%
Initiates: Buy
Price Target: $16
Current: $5.03
Upside: +218.41%
Initiates: Buy
Price Target: $20
Current: $2.33
Upside: +758.37%
Reinstates: Buy
Price Target: $4
Current: $1.13
Upside: +253.98%
Initiates: Buy
Price Target: $20
Current: $4.69
Upside: +326.44%
Initiates: Buy
Price Target: $18
Current: $2.31
Upside: +679.22%
Initiates: Buy
Price Target: $440
Current: $2.00
Upside: +21,900.00%
Initiates: Buy
Price Target: $75
Current: $0.35
Upside: +21,267.52%
Maintains: Buy
Price Target: $17$20
Current: $31.33
Upside: -36.16%
Maintains: Buy
Price Target: $440$200
Current: $1.90
Upside: +10,426.32%
Initiates: Buy
Price Target: $10
Current: $2.85
Upside: +251.49%
Initiates: Buy
Price Target: $800
Current: $5.99
Upside: +13,264.52%